Sanofi
Scope
Date
~
-
Bio & PharmaSK Bioscience, Sanofi to develop next-gen pneumococcal vaccines
South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...
Dec 23, 2024 (Gmt+09:00)
-
Bio & PharmaSK Bioscience applies Phase 3 trials in US for pneumococcal vaccine
South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...
Dec 11, 2023 (Gmt+09:00)
-
Bio & PharmaGC Biopharma, Sanofi to jointly market Plavix
GC Biopharma Co. (formerly Green Cross Corp.) said on Monday it has entered into a joint sales partnership with Sanofi-Aventis Korea, the South Kore...
Feb 13, 2023 (Gmt+09:00)
-
Bio & PharmaSanofi, Korean biotech Lemonex ink material transfer agreement
South Korean biotech Lemonex Inc. has signed a material transfer agreement (MTA) with global pharmaceutical giant Sanofi S.A. to use the Korean bi...
Sep 14, 2022 (Gmt+09:00)
-
PharmaceuticalsABL Bio in $1.06 bn deal with Sanofi for Parkinson's disease treatment
South Korea’s ABL Bio Inc. has signed a $1.06 billion contract to license out its technology for a Parkinson's disease treatment candidate t...
Jan 12, 2022 (Gmt+09:00)
Latest News
- 1 Micron set to supply SOCAMM chips to Nvidia ahead of Samsung, SK Hynix
- 2 POSCO Future M breaks with China in cathode supply chain
- 3 GIC resumes Seoul Finance Center sale in potential megadeal
- 4 South Korea’s Lee, China’s Xi agree on closer ties, peace on Korean Peninsula
- 5 Invesco, SK D&D likely to buy co-living building in Seoul
